Gilead Sciences, Second Genome announce strategic collaboration in biomarker and inflammatory bowel disease drug discovery

Gilead Sciences and Second Genome announced strategic collaboration in biomarker and inflammatory bowel disease drug discovery. (Credit: moritz320 from Pixabay)